![Robert Ross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Ross
Direttore/Membro del Consiglio presso
XILIO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/08/2026
Profilo
Robert W.
Ross is currently Chief Executive Officer at Clasp Therapeutics, Inc. since 2023.
Dr. Ross serves as Independent Director at Xilio Therapeutics, Inc. since 2022.
Dr. Ross is Director at Obsidian Therapeutics, Inc. since 2020 and again starting 2026.
Formerly, Dr. Ross was President, Chief Executive Officer & Director at Surface Oncology, Inc. from 2021 to 2023.
Dr. Ross was SVP-Clinical Development & Pharmacovigilance at Genetix Biotherapeutics, Inc. from 2015 to 2016.
Education includes undergraduate studies at Stanford University, graduate degrees from Harvard Medical School, and Columbia University College of Physicians & Surgeons.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Robert Ross
| Società | Posizione | Inizio |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 16/06/2022 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Direttore/Membro del Consiglio | 03/09/2020 |
ManaT Bio, Inc.
 ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Amministratore Delegato | 01/11/2023 |
Precedenti posizioni note di Robert Ross
| Società | Posizione | Fine |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Amministratore Delegato | 01/09/2023 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2016 |
Formazione di Robert Ross
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
60
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
ManaT Bio, Inc.
ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Health Technology |
